Author Correction: A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma

Autor:	Julie Westerlin Kjeldsen, Cathrine Lund Lorentzen, Evelina Martinenaite, Eva Ellebaek, Marco Donia, Rikke Boedker Holmstroem, Tobias Wirenfeldt Klausen, Cecilie Oelvang Madsen, Shamaila Munir Ahmed, Stine Emilie Weis-Banke, Morten Orebo Holmström, Helle Westergren Hendel, Eva Ehrnrooth, Mai-Britt Zocca, Ayako Wakatsuki Pedersen, Mads Hald Andersen, Inge Marie Svane
Rok vydání:	2022
Předmět:	General Medicine General Biochemistry Genetics and Molecular Biology
Zdroj:	Nature Medicine. 28:871-871
ISSN:	1546-170X 1078-8956
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::206d4ac7716edda86228f0ea08f14cbd https://doi.org/10.1038/s41591-022-01771-w Zobrazit plný text záznamu Full text from SpringerLink